DUBLIN--(BUSINESS WIRE)--The "Global Gynecology Partnering 2012-2018: Deal trends, players and financials" report has been added to ResearchAndMarkets.com's offering.
Global Gynecology Partnering 2012-2018: Deal trends, players and financials provides the full collection of Gynecology disease deals signed between the world's pharmaceutical and biotechnology companies since 2012.
- Trends in Gynecology partnering deals
- Financial deal terms for headline, upfront and royalty by stage of development
- Gynecology partnering agreement structure
- Gynecology partnering contract documents
- Top Gynecology deals by value
- Most active Gynecology dealmakers
Most of the deals included within the report occur when a licensee obtains a right or an option right to license a licensor's product or technology. More often these days these deals tend to be multi-component including both a collaborative R&D and a commercialization of outcomes element.
The report takes readers through the comprehensive Gynecology disease deal trends, key players and top deal values allowing the understanding of how, why and under what terms companies are currently entering Gynecology deals.
The report presents financial deal terms values for Gynecology deals, where available listing by overall headline values, upfront payments, milestones and royalties enabling readers to analyse and benchmark the value of current deals.
In conclusion, this report provides everything a prospective dealmaker needs to know about partnering in the research, development and commercialization of Gynecology technologies and products.
Key Topics Covered:
Chapter 1 - Introduction
Chapter 2 - Trends in Gynecology dealmaking
Chapter 3 - Financial deal terms for Gynecology partnering
Chapter 4 - Leading Gynecology deals and dealmakers
Chapter 5 - Gynecology contract document directory
Chapter 6 - Gynecology dealmaking by therapeutic target
For more information about this report visit https://www.researchandmarkets.com/research/kzrkm9/global_gynecology?w=4